Ads
related to: Vertex PharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. Stay Current on All Things Vertex and Hear From Leaders on Topics That Matter Most to Us.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Our Company
There’s no limit to what we can achieve together. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
Types:
Search results
Vertex is a biotechnology company that develops medicines for serious diseases, such as cystic fibrosis, sickle cell disease, and kidney disease. Learn about its latest news, clinical trials, acquisitions, and corporate responsibility report.
- Our Approved Medicines
Vertex’s Inclusion, Diversity and Equity Priorities Our...
- Our Company
In 2023, we ranked #12 in the Mega Employer category. Vertex...
- Our Science
Vertex Forward: Illustrating Our Scientific Strategy A...
- Patients
Vertex’s Inclusion, Diversity and Equity Priorities Our...
- Responsibility
At Vertex, giving back includes providing opportunities to...
- Our Approved Medicines
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
- 1989; 34 years ago
- Boston, Massachusetts, U.S.
- 4,800 (2022)
- US$8.93 billion (2022)
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko,...
Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.
People also ask
Where is vertex based?
What diseases does vertex treat?
What does vertex do?
Who is Vertex Pharmaceuticals?
Jan 30, 2024 · BOSTON -- (BUSINESS WIRE)--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of moderate-to-severe acute pain.
5,400. Get the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ...
Ad
related to: Vertex PharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. Stay Current on All Things Vertex and Hear From Leaders on Topics That Matter Most to Us.
